Morgan Stanley’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.16M | Sell |
4,209,670
-90,098
|
|
||||
|
2025
Q1 | $6.79M | Buy |
4,299,768
+103,899
|
|
||||
|
2024
Q4 | $7.51M | Buy |
4,195,869
+14,527
|
|
||||
|
2024
Q3 | $25.3M | Buy |
4,181,342
+3,494
|
|
||||
|
2024
Q2 | $22M | Sell |
4,177,848
-700
|
|
||||
|
2024
Q1 | $35.5M | Sell |
4,178,548
-4,194,608
|
|
||||
|
2023
Q4 | $55.3M | Buy |
8,373,156
+4,190,473
|
|
||||
|
2023
Q3 | $12.9M | Buy |
4,182,683
+312,603
|
|
||||
|
2023
Q2 | $10.4M | Buy |
3,870,080
+764,865
|
|
||||
|
2023
Q1 | $9.22M | Buy |
3,105,215
+1,098,738
|
|
||||
|
2022
Q4 | $5.06M | Sell |
2,006,477
-99,542
|
|
||||
|
2022
Q3 | $3.83M | Sell |
2,106,019
-1,563,661
|
|
||||
|
2022
Q2 | $11.6M | Buy |
3,669,680
+2,119,150
|
|
||||
|
2022
Q1 | $9.58M | Buy |
1,550,530
+1,545,497
|
|
||||
|
2021
Q4 | $71K | Sell |
5,033
-108,948
|
|
||||
|
2021
Q3 | $912K | Sell |
113,981
-382,828
|
|
||||
|
2021
Q2 | $14.2M | Sell |
496,809
-76,158
|
|
||||
|
2021
Q1 | $16.6M | Buy |
572,967
+106,253
|
|
||||
|
2020
Q4 | $5.57M | Buy |
466,714
+119,895
|
|
||||
|
2020
Q3 | $2.39M | Buy |
346,819
+220,954
|
|
||||
|
2020
Q2 | $780K | Buy |
+125,865
|
|
||||
|
2020
Q1 | – | Sell |
-7,589
|
|
||||
|
2019
Q4 | $42K | Buy |
+7,589
|
|
||||
|
2018
Q1 | – | Sell |
-75
|
|
||||
|
2017
Q4 | $0 | Sell |
75
-500
|
|
||||
|
2017
Q3 | $3K | Buy |
+575
|
|
||||
|
2016
Q2 | – | Sell |
-183
|
|
||||
|
2016
Q1 | $12K | Hold |
183
|
|
||||
|
2015
Q4 | $15K | Sell |
183
-442
|
|
||||
|
2015
Q3 | $72K | Buy |
+625
|
|